Generic Name and Formulations:
Sulfacetamide sodium 10%; oph. soln; contains benzalkonium chloride.
Indications for BLEPH-10:
Susceptible infections of conjunctiva and cornea. Adjunct in trachoma.
Adults and Children:
<2months: not recommended. ≥2months: Conjunctivitis: 1–2 drops every 2–3 hrs during the day (less often at night). Trachoma: 2 drops every 2 hrs w. systemic therapy.
Purulent exudates may inactivate drug. Discontinue if hypersensitivity or rash occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Incompatible with silver-containing preparations. May be antagonized by PABA.
Local irritation, stinging, burning, superinfection, sensitization.
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|